Benn, Peter http://orcid.org/0000-0001-7917-6946
Article History
Received: 29 July 2022
Accepted: 6 August 2022
First Online: 31 August 2022
Competing interests
: PB is a consultant and holds stock options in Natera, Inc. He is also on an Advisory Board for Menarini Biomarkers.